Subscribe To
POP Biotechnologies’ SNAP Vaccine System Safe and Effective in a Phase II Clinical Trial for COVID-19
Featured Image for POP Biotechnologies Featured Image for POP Biotechnologies BUFFALO, N.Y., Nov. 30, 2022 (GLOBE NEWSWIRE) — POP Biotechnologies (POP BIO), a Buffalo, New York-based biopharmaceutical startup, announces the publication of an interim analysis of the Phase 2 clinical trial of EuCorVac-19, a recombinant protein vaccine displaying the SARS-CoV-2 receptor-binding domain (RBD) antigen on […] The post POP Biotechnologies’ SNAP Vaccine System Safe and Effective in a Phase II Clinical Tr...
Read More
Posted: Nov 30 2022, 20:01
Author Name: forextv
Views: 110523